Trial Profile
Clinical Trials Insight: 700009610
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2005
Price :
$35
*
At a glance
- Drugs Bremelanotide (Primary) ; Sildenafil
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Palatin Technologies; Pfizer
- 01 Dec 2005 New trial record.